Despite progress and advances in diagnostics and treatments, TB remains the world’s leading cause of death from an infectious disease. The WHO Global Tuberculosis Report 2025 reveals that progress towards the End TB and Sustainable Development Goal targets is lagging, with projections showing these goals might not be met until around the middle of the century. In 2024, an estimated 10·7 million people developed TB and 1·23 million died, including 160 000 people living with HIV. Since 2015, global incidence has dropped only 12% and mortality 29%, both far below the 2025 targets of 50% and 75%. The gap between End TB targets and reality has widened.
A comment, published in The Lancet, outlines what ending TB requires now – a new paradigm change of innovation, one that is structural, operational, and social, rather than solely biomedical.
Access the full comment here /free registration required/.
For more TB updates, check out the TB CAB Weekly Newsletter (Issue #38, 12 December 2025).
The newsletter is brought to you by the Global TB Community Advisory Board (TB CAB) with the support of Treatment Action Group (TAG) and the European AIDS Treatment Group (EATG). Subscribe to the newsletter here.
Source : The Lancet
Related HIV and Co-Infections News
-
The Lancet Global Health: Untangling the complex relationship between HIV-exposure and TB in children: A narrative review
-
Research Centre Borstel: Long-term cure rates for multidrug-resistant TB much better than expected
-
Liverpool School of Tropical Medicine: New pooled testing toolkit to help expand TB diagnosis to ‘missed millions’
Get involved
Are you living with HIV/AIDS? Are you part of a community affected by HIV/AIDS and co-infections? Do you work or volunteer in the field? Are you motivated by our cause and interested to support our work?
Subscribe
Stay in the loop and get all the important EATG updates in your inbox with the EATG newsletter. The HIV & co-infections bulletin is your source of handpicked news from the field arriving regularly to your inbox.